Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: Evidence for a role of extracellular calmodulin in fibroblast proliferation

British Journal of Haematology

Volumn 93, Issue 4, 1996, Pages 856-862

  Dalley, A ^a   Smith, J M ^a   Reilly, J T ^a   Mac Neil, S ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

bFGF; calmodulin; myelofibrosis; pathogenesis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CALMODULIN; EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; FEMALE; FIBROBLAST; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL;

EID: 0029996944     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1739.x     Document Type: Article

References (30)

1. Berlin, N.I. (1975) Diagnosis and classification of polycythemia vera. Seminars in Haematology, 12, 339-351.
2. Bernabei, P.A., Arcangeli, A., Casini, M., Grossi, A., Padovani, R. & Ferrini, P.R. (1986) Platelet-derived growth factor(s) mitogenic activity in patients with myeloproliferative disease. British Journal of Haematology, 63, 353-357.
3. Boynton, A.K., Whitfield, J.F. & McManus, J.P. (1980) Calmodulin stimulates DNA synthesis by rat liver cells. Biochemical and Biophysical Research Communications, 95, 745-749.
4. Brunner, G., Nguyen, H., Gabrilove, J., Rifkin, D.B. & Wilson, E.L. (1993) Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood, 81, 631-638.
5. Burstein, S.A., Malpass, T.W., Yee, E., Kadin, M., Brigden, M., Adamson, J.W. & Harker, L.A. (1984) Platelet factor 4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis. British Journal of Haematology, 57, 383-392.
6. Castro-Malaspina, H., Gay, R.E. & Thanwar, S.L. (1982) Characteristics of bone marrow fibroblast colony forming cells and their progeny in patients with myeloproliferative disorders. Blood, 59, 1046-1054.
7. Crocker, G., Dawson, R.A., Barton, C.H. & Mac Neil, S. (1988) An extracellular role for calmodulin-like activity in cell proliferation. Biochemical Journal, 135, 877-884.
8. Davidson, J.M. & Broadley, K.N. (1991) Manipulation of the wound-healing process with basic fibroblast growth factor. Annals of the New York Academy of Sciences, 638, 306-315.
9. Dawson, R.A. & Mac Neil, S. (1992) Mitogenic role for extracellular calmodulin-like activity in normal human umbilical vein endothelial cells. British Journal of Haematology, 82, 151-160.
10. Dolan, G., Forrest, P.L., Eastham, J.M. & Reilly, J.T. (1991) Reduced platelet PDGF levels in idiopathic myelofibrosis. British Journal of Haematology, 78, 586-588.
11. Duensing, S. & Atzpodien, J. (1995) Increased intracellular and plasma levels of basic fibroblast growth factor in B-cell chronic lymphatic leukemia. Blood, 85, 1978-1980.
12. Ealey, P.A., Yateman, M.E., Holt, S.J. & Marshall, N.J. (1988) A bioassay system for the determination of the potency of hormones and antibodies which mimic their action. Journal of Molecular Endocrinology, 1, R1-R4.
13. Eastham, J.M., Reilly, J.T. & Mac Neil, S. (1994) Raised urinary calmodulin levels in idiopathic myelofibrosis: possible implications for the aetiology of fibrosis. British Journal of Haematology, 86, 668-670.
14. Gersuk, G., Carmel, R. & Pattengale, P.K. (1989) Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disorders. Blood, 14, 2330-2334.
15. Goberdhan, N.J., Dawson, R.A., Freedlander, E. & Mac Neil, S. (1993) A calmodulin-like protein as an extracellular mitogen for the keratinocyte. British Journal of Dermatology, 129, 678-688.
16. Gorbachevskaya, L.V., Borovkova, T.V., Rybin, V.O. & Fedorov, N.A. (1983) Effect of exogenous calmodin on lymphocyte proliferation in normal subjects. Bulletins of Experimental Medical Biology, 95, 361-363.
17. Gospodarowicz, D., Ferrara, N., Schweigerer, L. & Neufeld, G. (1987) Structural characterization and biological functions of fibroblast growth factor. Endocrine Reviews, 8, 95-114.
18. Groopman, J.E. (1980) The pathogenesis of myelofibrosis in myeloproliferative disorders. Annals of Internal Medicine, 92, 857-858.
19. Jacobsen, R.J., Salo, A. & Fialkow, P.J. (1978) Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood, 51, 189-194.
20. Katoh, O., Kimura, A. & Kuramoto, A. (1988) Platelet-derived growth factor is decreased in patients with myeloproliferative disorders. American Journal of Hematology, 27, 276-280.
21. Mac Neil, S., Walker, S.W., Seid, J. & Tomlinson, S. (1984) Calmodulin in human serum and the specific release of calmodulin from calmodulin-rich-platelets. Bioscience Reports, 4, 643-650.
22. Mac Neil, S., Dawson, R.A., Crocker, G., Barton, C.H., Hanford, L., Metcalfe, R., McGurk, M. & Munro, D.S. (1988) Extracellular calmodulin and its association with epidermal growth factor in normal body fluids. Journal of Endocrinology, 118, 501-509.
23. Murphy, S., Iland, R., Rosenthal, D. & Laszlo, J. (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Seminars in Haematology, 23, 177-182.
24. Nguyen, M., Watanabe, H., Budson, A.E., Richie, J.P., Hayes, D.F. & Folkman, J. (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. Journal of the National Cancer Institute, 86, 356-361.
25. Reilly, J.T. (1994) Pathogenesis of idiopathic myelofibrosis: present status and future directions. British Journal of Haematology, 88, 1-8.
26. Schelling, M.E. (1991) FGF mediation of coronary angiogenesis. Annals of the New York Academy of Science, 638, 467-469.
27. Tomlinson, S., Mac Neil, S., Walker, S.W., Ollis, C.A., Merritt, J.E. & Brown, B.L. (1984) Calmodulin and cell function. Clinical Science, 66, 497-508.
28. Wang, J.C., Lang, H.D., Lichter, S., Weinstein, M. & Benn, P. (1992) Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. British Journal of Haematology, 80, 184-188.
29. Ward, H.P. & Block, M.H. (1971) The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine (Baltimore), 50, 357-420.
30. Woodward, B.J., Lenton, E.A. & Mac Neil, S. (1993) Requirement of preimplantation human embryos for extracellular calmodulin for development. Human Reproduction, 8, 272-276.